Your SlideShare is downloading. ×
0
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
APASL 1000 1030 n.theise
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

APASL 1000 1030 n.theise

447

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
447
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
17
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Stem Cells and Hepatocarcinogenesis Neil Theise, MD Depts. of Pathology and Medicine Beth Israel Medical Center – Albert Einstein College of Medicine New York City www.neiltheise.com
  • 2. Differentiation-Inducing Activity of Hydroxycamptothecin on Cancer Stem-Like Cells Derived from Hepatocellular Carcinoma. Zhang Y, Song WJ, Zhang FQ, Liu WH, Dou KF. Dig Dis Sci. 2011 Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. Shibuya M, Kondo F, Sano K, Takada T, Asano T. J Hepatobiliary Pancreat Sci. 2011 MicroRNAs involved in neoplastic transformation of liver cancer stem cells. Li R, Qian N, Tao K, You N, Wang X, Dou K. J Exp Clin Cancer Res. 2010 Dec 23;29:169. Complete response in 5 out of 38 patients with advanced hepatocellular carcinoma treated with stem cell differentiation stage factors: case reports from a single centre. Livraghi T, Ceriani R, Palmisano A, Pedicini V, Pich MG, Tommasini MA, Torzilli G. Curr Pharm Biotechnol. 2011 Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. Hepatology. 2011 Jan;53(1):160-70. The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. Kossatz U, Breuhahn K, Wolf B, Hardtke-Wolenski M, Wilkens L, Steinemann D, Singer S, Brass F, Kubicka S, Schlegelberger B, Schirmacher P, Manns MP, Singer JD, Malek NP. J Clin Invest. 2010 Nov 1;120(11):3820-33 Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Exp Mol Pathol. 2011 Feb;90(1):66-73 Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, Fukushima K, Shiina M, Yamagiwa Y, Kondo Y, Inoue J, Kakazu E, Iwasaki T, Kawagishi N, Shimosegawa T, Sugamura K. Cancer Sci. 2010 Oct;101(10):2145-5 Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Sasaki A, Kamiyama T, Yokoo H, Nakanishi K, Kubota K, Haga H, Matsushita M, Ozaki M, Matsuno Y, Todo S. Oncol Rep. 2010 Aug;24(2):537-46. Collecting evidence for a stem cell hypothesis in HCC. Teufel A, Galle PR. Gut. 2010 Jul;59(7):870-1Expression of Oct4 in HCC and modulation to wnt/βcatenin and TGF-β signal pathways. Yuan F, Zhou W, Zou C, Zhang Z, Hu H, Dai Z, Zhang Y. Mol Cell Biochem. 2010 Oct;343(1-2):155-62Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, Fukushima K, Shiina M, Yamagiwa Y, Kondo Y, Inoue J, Kakazu E, Iwasaki T, Kawagishi N, Shimosegawa T, Sugamura K Cancer Sci. 2010 Oct;101(10):2145-55Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S. Cancer Res. 2010 Jun 1;70(11):4687-97EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B, Cavard C, Perret C. J Hepatol. 2010 Feb;52(2):280-1. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells. Li JP, Zheng JY, Du JJ, Zhang R, Yang AG. Hepatology. 2009 Dec;50(6):2047-Hepatic progenitor cells in liver cancers from Asian children. Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K. Liver Int. 2010 Jan;30(1):102-11EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW. Gastroenterology. 2009 Mar;136(3):1012-24Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, Wu J. Exp Mol Pathol. 2010 Aug;89(1):27-35.
  • 3. Neil Theise, MD Depts. of Pathology and Medicine Beth Israel Medical Center – Albert Einstein College of Medicine New York City www.neiltheise.com Cancer and Stem Cells and Stem Cell-derived Cancer and Cancer-derived Stem Cells and… and… and… and…
  • 4. This talk has been posted on: www.slideshare.net Search: “Neil Theise”
  • 5. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>5. Do all hepatobiliary tumors have stem cells? </li></ul>
  • 6. <ul><li>Are there hepatobiliary stem cells? </li></ul>Yes, in the: canals of Hering bile ducts bone marrow Perhaps also: peribiliary “null cell” monocytes peribiliary hepatocytes
  • 7. stem cell
  • 8. stem cell “ assymetric division”
  • 9. stem cell
  • 10. stem cell
  • 11. stem cell transit amplifying cells
  • 12. stem cell transit amplifying cells ductular reactions (humans) oval cells (rodents)
  • 13. stem cell transit amplifying cells drug resistant hypoxia resistant radio-resistant
  • 14. stem cell transit amplifying cells drug resistant hypoxia resistant radio-resistant i.e. resistant to mutations
  • 15. stem cell transit amplifying cells drug resistant hypoxia resistant radio-resistant telomerase
  • 16. stem cell transit amplifying cells Keratin 19 CD117 (c-kit) CD90 (thy-1) EpCAM CD 133 (prominin-1) ABC-G2
  • 17. Keratin 19 CD117 (c-kit) CD90 (thy-1) EpCAM CD 133 (prominin-1) ABC-G2 stem cell transit amplifying cells “ Side Population”
  • 18. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul>
  • 19. <ul><li>Combined hepatocellular/cholangiocarcinomas </li></ul>Is there evidence that hepatobiliary cancers arise from stem cells?
  • 20. <ul><li>Combined hepatocellular/cholangiocarcinomas </li></ul><ul><li>Combined HCC/ChC arising in a dysplastic nodule </li></ul>Harada K, Terada T, Nakanuma Y, Furukawa Y, Kurumaya H. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver. Am. J. Gastroenterol. 1993; 88; 1968–1969. Is there evidence that hepatobiliary cancers arise from stem cells?
  • 21. <ul><li>Combined hepatocellular/cholangiocarcinomas </li></ul><ul><li>Combined HCC/ChC arising in a dysplastic nodule </li></ul><ul><li>“ Stem cell tumors” of the liver </li></ul>Is there evidence that hepatobiliary cancers arise from stem cells?
  • 22. 1. Combined HCC-ChC 2. Combined HCC-ChC with stem cell features A. typical subtype B. intermediate cell subtype C. cholangiocellular subtype Chapter 10-4, N. D. Theise, O. Nakashima, Y. N. Park, Y. Nakanuma
  • 23. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul>
  • 24. Stem Cell Niche
  • 25. Stem Cell Stromal Cell
  • 26. Immortal Strand Hypothesis Stem cell retention of original DNA template after replication and division
  • 27. Immortal Strand Hypothesis Stem cell retention of original DNA template after replication and division SO: STEM CELLS SHOULD REMAIN FREE OF MUTATIONS
  • 28. Disordered stem cell retention of original DNA template in chronic disease e.g. inflammatory bowel disease primary sclerosing cholangitis mammary fibrocystic disease chronic viral hepatitis H. pylori gastritis
  • 29. Disordered stem cell retention of original DNA template in chronic disease
  • 30. Disordered stem cell retention of original DNA template in chronic disease
  • 31. Disordered stem cell retention of original DNA template in chronic disease
  • 32. Disordered stem cell retention of original DNA template in chronic disease MUTATION!!
  • 33. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul>
  • 34. Carcinogenesis
  • 35. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>No. Mutations can probably happen in all cell types: </li></ul><ul><li>Stem cells </li></ul><ul><li>Progenitor cells (ductular reactions!) </li></ul><ul><li>Fully differentiated cells </li></ul>
  • 36. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>5. Do all hepatobiliary tumors have stem cells? </li></ul>
  • 37. Cancer Stem Cell EpCAM CD133 ABC-G2 CD90 tumor
  • 38. Cancer Stem Cell EpCAM CD133 ABC-G2 CD90 Often tumor initiating… tumor
  • 39. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>Do all hepatobiliary tumors have stem cells? </li></ul><ul><li> </li></ul>
  • 40. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>Do all hepatobiliary tumors have stem cells? </li></ul><ul><li>Many do, though not necessarily all… </li></ul>
  • 41. <ul><li>Are there hepatobiliary stem cells? </li></ul><ul><li>Is there evidence that hepatobiliary cancers arise from </li></ul><ul><li>stem cells? </li></ul><ul><li>3. How can hepatobiliary carcinomas arise from stem cells? </li></ul><ul><li>4. Do all hepatobiliary tumors, then, start from stem cells? </li></ul><ul><li>Do all hepatobiliary tumors have stem cells? </li></ul><ul><li>So what…? </li></ul>
  • 42. cancer stem cell drug resistant hypoxia resistant radio-resistant tumor
  • 43. Anti-tumor therapy cancer stem cell drug resistant hypoxia resistant radio-resistant tumor
  • 44. Anti-tumor therapy cancer stem cell drug resistant hypoxia resistant radio-resistant tumor
  • 45. Anti-tumor therapy cancer stem cell drug resistant hypoxia resistant radio-resistant tumor
  • 46. Anti-tumor therapy cancer stem cell drug resistant hypoxia resistant radio-resistant tumor
  • 47. Anti-tumor therapy cancer stem cell drug resistant hypoxia resistant radio-resistant
  • 48. cancer stem cell drug resistant hypoxia resistant radio-resistant
  • 49. cancer stem cell
  • 50. cancer stem cell
  • 51. cancer stem cell
  • 52. cancer stem cell
  • 53. cancer stem cell So: successful treatments will depend on new therapies that can successively eradicate tumor stem cells.
  • 54. In summary: Cancers can arise from stem cells
  • 55. In summary: Cancers can arise from stem cells or Cancers can arise from differentiated cells
  • 56. In summary: Cancers can arise from stem cells or Cancers can arise from differentiated cells “ Cancer stem cells” may refer to the stem cells from which cancers start, BUT generally refer to:
  • 57. In summary: Cancers can arise from stem cells or Cancers can arise from differentiated cells “ Cancer stem cells” can refer to the stem cells from which some cancers start, BUT generally refer to the: cells within a tumor that have stem cell-like properties :
  • 58. In summary: Cancers can arise from stem cells or Cancers can arise from differentiated cells “ Cancer stem cells” can refer to the stem cells from which some cancers start, BUT generally refer to the: cells within a tumor that have stem cell like properties: i.e. slow cycling self-renewal multidrug resistance hypoxia resistant radio-insensitive
  • 59. In summary: Cancers can arise from stem cells or Cancers can arise from differentiated cells “ Cancer stem cells” can refer to the stem cells from which some cancers start, BUT generally refer to the: cells within a tumor that have stem cell like properties: i.e. slow cycling self-renewal multidrug resistance hypoxia resistant radio-insensitive and therefore are resistant to therapy and responsible for tumor recurrence…
  • 60. cells within a tumor that have stem cell like properties: i.e. slow cycling self-renewal multidrug resistance hypoxia resistant radio-insensitive and therefore are resistant to therapy and responsible for tumor recurrence… Antigenic Markers : CD133 c-kit EpCAM Keratin 19 Functional Markers : Side population Label retaining cells
  • 61. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. Marquardt JU, Factor VM, Thorgeirsson SS. J Hepatol. 2010; 53: 568. Stem cell plasticity: recapping the decade, mapping the future. Theise ND. Exp Hematol. 2010; 38: 529. FURTHER READING
  • 62.  

×